Panoramic Parvovirus Strain Discovery Data Chain
| ParvoDB ID | PV028547 | GenBank Accession | KC823115 |
| Subfamily | Parvovirinae | Genus | Bocaparvovirus |
| Species | Bocaparvovirus primate1 | Sequence Length | 5146 |
| Definition | Human bocavirus strain Irish, complete genome. | Submission Date | 2013-03-26 |
| Strain Name | Irish | Sampling Date | 2012 |
| Sampling Country | Ireland | Location | Ireland |
| Submitted By | Sadeghi,M., Kantola,K., McCaughey,C., Finnegan,D., Hedman,L., Soderlund-Venermo,M. and Hedman,K. | Submitting Institution | Department of Virology, Haartman Institute, University of Helsinki, Haartmaninkatu 3, Helsinki, Helsinki FIN-00014, Finland |
| Original Host | Homo sapiens | Sample Type | Blood, tracheal aspirate, and sputum samples |
| Standardized Host Name | Homo sapiens | Host Tax Rank | species |
| Standardized Host Class | Mammalia | Standardized Host Order | Primates |
| Environmental Origin | - N/A - | Reagent Origin | - N/A - |
| Number | Reagent/Consumables | Purpose | PMID/Url | Reference |
|---|---|---|---|---|
| 1 | Azacitidine | Used for treatment of relapsed chronic lymphocytic leukemia and secondary hypogammaglobulinemia. | 23903541 | View Related Publication |
| 2 | Co-trimoxazole | Administered as a prophylactic dose for unspecified infection prevention. | ||
| 3 | Intravenous immunoglobulin | Administered monthly as a prophylactic treatment for recurrent infections due to hypogammaglobulinemia. | ||
| 4 | Oral corticosteroid | Started in view of the patient’s history of chronic obstructive pulmonary disease. | ||
| 5 | Clarithromycin | Administered intravenously, presumably for treating bacterial pneumonia or an atypical chest infection. | ||
| 6 | Piperacillin with tazobactam | Administered intravenously in conjunction with clarithromycin to treat suspected bacterial pneumonia. | ||
| 7 | Fluconazole | Given to treat presumed pharyngeal thrush. | ||
| 8 | Meropenem | Administered when the patient’s condition worsened to cover for multidrug-resistant bacterial infections. | ||
| 9 | Teicoplanin | Introduced along with Meropenem to broaden antimicrobial coverage. | ||
| 10 | High-dose co-trimoxazole | Introduced to cover possible Pneumocystis jirovecii pneumonia. | ||
| 11 | Respiratory samples (sputum and tracheal secretions) | Collected post-mortem for pathogen detection by PCR/quantitative PCR. | ||
| 12 | Blood sample | Collected post-mortem on the day patient died to assess pathogen DNA levels. | ||
| 13 | High-fidelity PCR | Used to clone the viral genome from the sputum sample for almost entire HBoV1 genome sequence determination. | ||
| 14 | Virus-like particles | Used in competition enzyme immunoassay (EIA) to test for IgG and IgM antibodies against HBoV1 to HBoV4. |